HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹1,011 Cr | ₹933 Cr | ₹662 Cr | ₹828 Cr | ₹703 Cr |
What is the latest Total Current Liabilities ratio of HIKAL ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹1,011 Cr |
| Mar2024 | ₹933 Cr |
| Mar2023 | ₹662 Cr |
| Mar2022 | ₹828 Cr |
| Mar2021 | ₹703 Cr |
How is Total Current Liabilities of HIKAL Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,011 Cr | 8.36 | |
| Mar2024 | ₹933 Cr | 41.00 | |
| Mar2023 | ₹662 Cr | -20.12 | |
| Mar2022 | ₹828 Cr | 17.75 | |
| Mar2021 | ₹703 Cr | - | |
Compare Total Current Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,741.6 Cr | 0.4% | -2.8% | -29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,431.0 Cr | -2.3% | 3% | 12.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,115.0 Cr | 2.9% | 22.7% | 25.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,853.0 Cr | -2.7% | 2% | 33.9% | Stock Analytics | |
| CIPLA | ₹119,158.0 Cr | 0.1% | 3% | -7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | 2.4% | -12.9% | -9.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 0.4% |
-2.8% |
-29.5% |
| SENSEX | 1.3% |
1% |
-2.9% |
You may also like the below Video Courses